Deferoxamine mesylate injection Shortage
Last Updated: May 17, 2016
Status: Resolved
Products Affected - Description
-
- Desferal injection, Novartis, 2 gram, vial, 4 count, NDC 00078-0347-51
Reason for the Shortage
-
- Fresenius Kabi has deferoxamine available.
- Hospira has deferoxamine available.
- Novartis discontinued Desferal 2 gram vials in 2015. The 500 mg vials are available.
- Teva discontinued all deferoxamine presentations in 2013.
- West-Ward discontinued deferoxamine in September 2014.
- Watson discontinued all deferoxamine presentations.
Available Products
-
- Desferal injection, Novartis, 500 mg, vial, 4 count, NDC 00078-0467-91
- Deferoxamine injection, Fresenius Kabi, 2 gram, vial, 1 count, NDC 63323-0599-30
- Deferoxamine injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0597-10
- Deferoxamine injection, Pfizer, 2 gram, vial, 4 count, NDC 00409-2337-25
- Deferoxamine injection, Pfizer, 500 mg, vial, 4 count, NDC 00409-2336-10
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated May 17, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 23, 2010 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.